[ET Net News Agency, 28 March 2025] LEPU BIO-B (02157) rose 19.9% to HK$3.91, breaking
above the 250-D SMA of HK$3.387.
It hits an intra-day high of HK$3.98, and an intra-day low of HK$3.31. The total shares
traded was 27.1 million, with a value of HK$100.55m. The active buy/sell ratio is 65:35,
with net buying turnover of HK$28.61m. UBS accounts for greatest net responsive buying
turnover of HK$1.29m, with volume weighted average price of HK$3.725. CHINA INV INFO
accounts for greatest net responsive selling turnover of HK$5.92m, with volume weighted
average price of HK$3.713. The stock has risen a combined 25.3% over the past 3
consecutive trading days.

Basic Information
=================

---------------------------------
Nominal 3.910 % Chg +19.94%
High 3.980 Low 3.310
Shares Tr 27.1m Turnover 100.55m
10-D SMA 3.343 %H.V 61.339
20-D SMA 3.342 VWAP 3.710
50-D SMA 3.095 RSI14 66.138
---------------------------------
Status: Breaking above the 250-D SMA, active buy/sell ratio is 65:35, with net buying
turnover of HK$28.61m, rising a combined 25.3% over the past 3 consecutive trading days

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
---------------------------------------------
LEPU BIO-B (02157) 3.91 +19.94
HUTCHMED (00013) 25.95 +7.68
INNOVENT BIO (01801) 47.30 +3.16
EVEREST MED-B (01952) 57.95 +7.51
WUXI BIO (02269) 27.35 -1.44
BEIGENE (06160) 165.50 +3.70
ASCENTAGE-B (06855) 43.80 +9.36
ZAI LAB (09688) 31.50 +13.51
AKESO (09926) 74.70 +5.29
REMEGEN (09995) 25.05 +12.58
---------------------------------------------
(ed)